Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells

Mol Cell Biochem. 2005 Sep;277(1-2):171-9. doi: 10.1007/s11010-005-5995-3.

Abstract

Evidence suggests that fibrin deposit is related to severity of glomerulonephropathy. Fibrin is considered to play an active role beyond a haemostatic plug or temporary matrix in response to injury. We have reported that fibrin induced specific morphological changes and up-regulated intercellular adhesion molecule-1 expression of glomerular endothelial cells (GECs). Changes of gelatinases activity have been implicated playing a prominent role in glomerular diseases involving matrix turnover. This study examined whether overlying fibrin influences the expression of gelatinase A and B in cultured human GECs and mechanism underlying the activation. No gelatinase activity was detectable in supernatant of cultured GECs; however, physiological concentration of fibrin (0.5-2.0 mg/ml) induced a dramatic expression of activated MMP-2 and MMP-9 at both mRNA and protein level in a dose and time dependent manner. Increased mRNA level of membrane-type 1 matrix metalloproteinases (MT1-MMPs) was also found. Interestingly, we observed that fibrin also induced the expression of tissue type plasminogen activator (tPA), urokinase type plasminogen activator (uPA) and plasminogen activator inhibitor-1 by casein zymographic and reverse zymographic analysis. Fibrin plate assay revealed the net activity was PA predominant. Serine protease inhibitor aprotinin blocked the conversion of pro-gelatinase A and B to their active forms. The results demonstrate that overlying fibrin increased the secretion of gelatinase A and B from GECs. PA/plasmin proteolytic pathways contributed to the activation of gelatinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cells, Cultured
  • DNA / genetics
  • Endothelial Cells / metabolism
  • Enzyme Activation / drug effects
  • Fibrin / pharmacology*
  • Fibrinolysin / metabolism*
  • Gelatinases / genetics
  • Gelatinases / metabolism*
  • Humans
  • Kidney Glomerulus / drug effects
  • Kidney Glomerulus / metabolism*
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinases, Membrane-Associated
  • Metalloendopeptidases / genetics
  • Metalloendopeptidases / metabolism
  • Plasminogen Activators / metabolism*
  • Plasminogen Inactivators / genetics
  • Plasminogen Inactivators / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Plasminogen Inactivators
  • RNA, Messenger
  • Fibrin
  • DNA
  • Plasminogen Activators
  • Fibrinolysin
  • Gelatinases
  • Matrix Metalloproteinases, Membrane-Associated
  • Metalloendopeptidases
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9